康希诺生物

Information Disclosure

Home >Investor Relations >Information Disclosure

H Share

TERMS OF REFERENCE FOR THE REMUNERATION AND ASSESSMENT COMMITTEE OF THE BOARD
TERMS OF REFERENCE FOR THE NOMINATION COMMITTEE OF THE BOARD
TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD
(1) PROPOSED CANCELLATION OF THE BOARD OF SUPERVISORS AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THE RULES OF PROCEDURES; (2) PROPOSED AMENDMENTS TO THE CORPORATE GOVERNANCE RULES; (3) RESIGNATION OF DIRECTORS AND (4) PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS
THIRD QUARTERLY REPORT FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025
POLL RESULTS OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING
NOTICE OF BOARD MEETING
Revised Form of Proxy for use at the 2025 First Extraordinary General Meeting to be held on Thursday, October 23, 2025
Monthly Return of Equity Issuer on Movements in Securities
Form of Proxy for use at the 2025 First Extraordinary General Meeting to be held on Thursday, October 23, 2025

1 2 3 4 5 6 48